NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery
MOUNTAIN VIEW, California., Aug 11, 2022 (GLOBE NEWSLETTER) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people with epilepsy, today announced that the company has entered into a commercialization agreement with DIXI Medical® United States (“DIX”). NeuroPace will be the exclusive U.S distributor of DIXI’s product line … Read more